Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A van Oosterom

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
European Journal of Cancer & Clinical Oncology|January 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative groupR Paridaens, H T Mouridsen, T Palshof, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1989
The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, A van Oosterom, H T Mouridsen, et al.
Journal of the National Cancer Institute|May 3, 1995
Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancerM J Piccart, M Gore, W Ten Bokkel Huinink, et al.
Seminars in Surgical Oncology|January 1, 1988
Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of CancerV H Bramwell, A Santoro, J Rouesse, et al.
Japanese Journal of Cancer Research : Gann|January 1, 1994
5'-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expressionS van der Heyden, E Gheuens, W van de Vrie, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, J Verweij, R Fuchs, et al.
Blood|May 1, 1995
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib studyV D'Hondt, Y Humblet, T Guillaume, et al.
Clinical Chemistry|June 1, 1995
Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serumV O Van Hoof, M Martin, P Blockx, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
Investigational New Drugs|January 1, 1985
Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European studyH T Mouridsen, M Cornbleet, R Stuart-Harris, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
European Journal of Cancer & Clinical Oncology|January 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative groupR Paridaens, H T Mouridsen, T Palshof, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1989
The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, A van Oosterom, H T Mouridsen, et al.
Journal of the National Cancer Institute|May 3, 1995
Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancerM J Piccart, M Gore, W Ten Bokkel Huinink, et al.
Seminars in Surgical Oncology|January 1, 1988
Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of CancerV H Bramwell, A Santoro, J Rouesse, et al.
Japanese Journal of Cancer Research : Gann|January 1, 1994
5'-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expressionS van der Heyden, E Gheuens, W van de Vrie, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, J Verweij, R Fuchs, et al.
Blood|May 1, 1995
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib studyV D'Hondt, Y Humblet, T Guillaume, et al.
Clinical Chemistry|June 1, 1995
Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serumV O Van Hoof, M Martin, P Blockx, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
Investigational New Drugs|January 1, 1985
Mitoxantrone as first-line chemotherapy in advanced breast cancer: results of a collaborative European studyH T Mouridsen, M Cornbleet, R Stuart-Harris, et al.
Pageof 15